Heron Therapeutics
NC - CaryBiotechnology
Focus: Heron Therapeutics is a specialty biotech focused on polymer-based drug delivery platforms across oncology, gastroenterology, neurology, musculoskeletal, and infectious diseases. The company generates 62% of revenue from CINVANTI, indicating heavy dependence on a single product.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Open Jobs
26+23 this month
Hot — 24 jobs added in 30d
Net +23 (24 new, 1 removed). Aggressive expansion phase.
Should You Work at Heron Therapeutics?
AI assessmentHeron offers polymer-delivery expertise and near-term pipeline catalysts, but extreme product concentration and minimal hiring signal a company in consolidation mode—suitable only for risk-tolerant professionals seeking specialized drug-delivery experience.
Why Work Here
- Proprietary polymer-based delivery platform differentiates the company in high-value markets like oncology and pain management
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$142K Part DStable
Peak
Help build intelligence for Heron Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.